Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

35.40p
   
  • Change Today:
      0.25p
  • 52 Week High: 70.00p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,314,613
  • Market Cap: £191.30m
  • RiskGrade: 119

Latest ShareCast News

Butterfield out, Sedgwick in as Alliance Pharma CEO

By Josh White

Date: Wednesday 08 May 2024

(Sharecast News) - Alliance Pharma announced a significant leadership transition on Wednesday, with chief executive Peter Butterfield stepping down from his role to pursue other business interests.

Alliance Pharma delays preliminary results

By Josh White

Date: Monday 22 Apr 2024

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.

Alliance Pharma to delay release of 2023 results

By Benjamin Chiou

Date: Friday 05 Apr 2024

(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.

Alliance Pharma names Camillo Pane as chair 05-Feb-2024 ShareCast
RBC Capital Markets nudges down Alliance Pharma ... 31-Jan-2024 ShareCast
Alliance Pharma expects no profit growth in 2024 29-Jan-2024 ShareCast
Alliance Pharma confident after some first-half ... 26-Sep-2023 ShareCast
Alliance Pharma reports resilient first-half tra... 18-Jul-2023 ShareCast
Currency headwinds to impact Alliance Pharma pro... 25-May-2023 ShareCast
Alliance Pharma confident despite weak results 21-Mar-2023 ShareCast
Alliance Pharma ends year in line with recent fo... 17-Jan-2023 ShareCast
Alliance Pharma adds operations chief to managem... 12-Jan-2023 ShareCast
Alliance Pharma tumbles amid slower market recov... 23-Nov-2022 ShareCast
Alliance Pharma revenue rises, profits narrow in... 20-Sep-2022 ShareCast
Alliance Pharma appeals competition disqualifica... 02-Sep-2022 ShareCast
Alliance Pharma shares slide following challengi... 20-Jul-2022 ShareCast
Alliance Pharma in 'good health' amid strong dem... 18-May-2022 ShareCast
Alliance Pharma upbeat on prospects for US acqui... 25-Mar-2022 ShareCast
Alliance Pharma reports 'strong' 2021 performance 22-Mar-2022 ShareCast
CMA issues £35m in fines for illegal anti-nausea... 03-Feb-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 35.40p
Change Today 0.25p
% Change 0.71 %
52 Week High 70.00p
52 Week Low 29.35p
Volume 1,314,613
Shares Issued 540.40m
Market Cap £191.30m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.33% above the market average92.33% above the market average92.33% above the market average92.33% above the market average92.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
68.62% below the market average68.62% below the market average68.62% below the market average68.62% below the market average68.62% below the market average
14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average
Income
32.16% above the market average32.16% above the market average32.16% above the market average32.16% above the market average32.16% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
89.29% below the market average89.29% below the market average89.29% below the market average89.29% below the market average89.29% below the market average
88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 17-May-2024

Time Volume / Share Price
16:35 68,902 @ 35.40p
16:35 618 @ 35.40p
16:35 491 @ 35.40p
16:35 2,455 @ 35.40p
16:35 2,462 @ 35.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page